RBC Life Sciences, Inc. (RBCL) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate RBC Life Sciences, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
-0.88
Earnings Deficit
P/B Ratio
0.09
Strong
WeakModerateStrong
Earnings Yield
-113.91%
Yield Gap
Profitability Health
2016Return on Equity
-10.61%
Weak
WeakModerateStrong
Operating Margin
-2.59%
Weak
WeakModerateStrong
Net Profit Margin
-2.93%
Weak
WeakModerateStrong
Growth Indicators
2016Revenue Growth
5.78%
Moderate
WeakModerateStrong
Net Income Growth
-1.95%
Weak
WeakModerateStrong
EPS Growth
-
No data
Efficiency & Liquidity
2016Current Ratio
2.28
Strong
WeakModerateStrong
Quick Ratio
1.05
Moderate
WeakModerateStrong
Asset Turnover
2.35x
Strong
WeakModerateStrong
Inventory Turnover
2.93x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
1.01%
Weak
WeakModerateStrong
EV / Free Cash Flow
-120.45x
Strong
WeakModerateStrong
Net Debt / EBITDA
5.85x
Weak
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.000
Strong
WeakModerateStrong
Return on Invested Capital
-8.78%
Weak
WeakModerateStrong
Cash Conversion Cycle
92.87 days
Weak
WeakModerateStrong
Fortress screener guardrails
0/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for RBCL.
View Financial Statements